Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Guan-Yang Lin"'
Autor:
Xu-ben Yu, Xiao-Shan Zhang, Ye-Xuan Wang, Yu-Zhen Wang, Hong-Min Zhou, Fang-Min Xu, Jun-Hui Yu, Li-Wen Zhang, Ying Dai, Zi-Ye Zhou, Chun-Hong Zhang, Guan-Yang Lin, Jing-Ye Pan
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Presently, colistin is commercially available in two different forms, namely, colistin sulfate and its sulphomethylated derivative, colistimethate sodium (CMS). However, in the currently reported studies, most of the clinical studies on c
Externí odkaz:
https://doaj.org/article/13ed42dfb64c42aaba3889af77b11d2a
Autor:
Fan Wu, Xiao-Shan Zhang, Ying Dai, Zi-Ye Zhou, Chun-Hong Zhang, Lu Han, Fang-Min Xu, Ye-Xuan Wang, Da-Wei Shi, Guan-Yang Lin, Xu-Ben Yu, Fang Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Linezolid is associated with myelosuppression, which may cause failure in optimally treating bacterial infections. The study aimed to define the pharmacokinetic/toxicodynamic (PK/TD) threshold for critically ill patients and to identify a
Externí odkaz:
https://doaj.org/article/44d10f8c8cd04fa189b234dace9c47a9
Autor:
Jie Fang, Xiao-Shan Zhang, Chun-Hong Zhang, Zi-Ye Zhou, Lu Han, Ye-Xuan Wang, Xiao-Shuang He, Xiao-Lan Bian, Guan-Yang Lin, Zheng Jiao, Ying Dai, Xu-Ben Yu, Jing-Ye Pan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Evidence supports linezolid therapeutic drug monitoring as the exposure–response relationship has been identified for toxicity among patients receiving linezolid, but the data to establish the upper limit are limited and the published toxicity thre
Externí odkaz:
https://doaj.org/article/c5dca0261dcb4de9b8c69163527910eb
Autor:
Xu‐Ben Yu, Yue‐Yue Huang, Xiao‐Shan Zhang, Yu‐Zhen Wang, Da‐Wei Shi, Chun‐Hong Zhang, Jie Chen, Xiao‐Rong Wang, Guan‐Yang Lin
Publikováno v:
British Journal of Clinical Pharmacology. 88:3490-3494
Autor:
Xuben Yu, Lu Han, Zheng Jiao, Guan-Yang Lin, Chun-Hong Zhang, Ziye Zhou, Jing-Ye Pan, Changcheng Sheng, Xin Wen, Ying Dai
Publikováno v:
British Journal of Clinical Pharmacology. 87:1869-1877
Aims Current FDA-approved label recommends that the dosage of polymyxin B should be adjusted according to renal function. However, the correlation between polymyxin B pharmacokinetics (PK) and creatinine clearance (CrCL) is poor. This study aimed to
Autor:
Xiao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Fang-Min Xu, Jun-Hui Yu, Jie Chen, Guan-Yang Lin, Chun-Hong Zhang, Xu-Ben Yu, Cong-Rong Tang
Publikováno v:
Infectious diseases and therapy. 11(6)
Limited data are available for ceftazidime-avibactam (CZA) dosing in patients receiving renal replacement therapy, especially the data on the dosing in patients receiving intermittent hemodialysis (IHD). In this report, we firstly described a case in
Autor:
Xiao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Fang-Min Xu, Jun-Hui Yu, Jie Chen, Guan-Yang Lin, Chun-Hong Zhang, Xu-Ben Yu, Cong-Rong Tang
Publikováno v:
Infectious Diseases and Therapy. 11:2321-2321
Autor:
Xian-Qin, Wang, Xiao-Jun, Pan, Guan-Yang, Lin, Zheng, Xiang, Xue-Bao, Wang, Jian-Zhang, Wu, Dan, Lin
Publikováno v:
Fa yi xue za zhi. 25(2)
To develop a method for determination of clozapine, olanzapine and mirtazapine in human plasma by liquid chromatography-tandem mass spectrometry(LC-MS/MS).Clozapine, olanzapine and mirtazapine were extracted from plasma samples by using diethyl ether